These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20637096)

  • 21. Hyperactive behaviour in the mouse model of mucopolysaccharidosis IIIB in the open field and home cage environments.
    Langford-Smith A; Malinowska M; Langford-Smith KJ; Wegrzyn G; Jones S; Wynn R; Wraith JE; Wilkinson FL; Bigger BW
    Genes Brain Behav; 2011 Aug; 10(6):673-82. PubMed ID: 21635693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Murine cellular model of mucopolysaccharidosis, type IIIB (MPS IIIB) - A preliminary study with particular emphasis on the non-oxidative l-cysteine metabolism.
    Kaczor-Kamińska M; Stalińska K; Kamiński K; Pisarek A; Maziarz U; Feldman A; Wróbel M
    Biochimie; 2020 Jul; 174():84-94. PubMed ID: 32335228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracranial gene delivery of LV-NAGLU vector corrects neuropathology in murine MPS IIIB.
    Di Domenico C; Villani GR; Di Napoli D; Nusco E; Calì G; Nitsch L; Di Natale P
    Am J Med Genet A; 2009 Jun; 149A(6):1209-18. PubMed ID: 19449420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temporospatial Development of Neuropathologic Findings in a Canine Model of Mucopolysaccharidosis IIIB.
    Harm TA; Hostetter SJ; Nenninger AS; Valentine BN; Ellinwood NM; Smith JD
    Vet Pathol; 2021 Jan; 58(1):205-222. PubMed ID: 33205707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: Diagnostic, clinical, and biological implications.
    Yogalingam G; Hopwood JJ
    Hum Mutat; 2001 Oct; 18(4):264-81. PubMed ID: 11668611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB.
    Ohmi K; Greenberg DS; Rajavel KS; Ryazantsev S; Li HH; Neufeld EF
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1902-7. PubMed ID: 12576554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted Metabolomic Analysis of a Mucopolysaccharidosis IIIB Mouse Model Reveals an Imbalance of Branched-Chain Amino Acid and Fatty Acid Metabolism.
    De Pasquale V; Caterino M; Costanzo M; Fedele R; Ruoppolo M; Pavone LM
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retrovirally transduced bone marrow has a therapeutic effect on brain in the mouse model of mucopolysaccharidosis IIIB.
    Zheng Y; Ryazantsev S; Ohmi K; Zhao HZ; Rozengurt N; Kohn DB; Neufeld EF
    Mol Genet Metab; 2004 Aug; 82(4):286-95. PubMed ID: 15308126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytokines, neurotrophins, and oxidative stress in brain disease from mucopolysaccharidosis IIIB.
    Villani GR; Gargiulo N; Faraonio R; Castaldo S; Gonzalez Y Reyero E; Di Natale P
    J Neurosci Res; 2007 Feb; 85(3):612-22. PubMed ID: 17139681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Near-Complete Correction of Profound Metabolomic Impairments Corresponding to Functional Benefit in MPS IIIB Mice after IV rAAV9-hNAGLU Gene Delivery.
    Fu H; Meadows AS; Ware T; Mohney RP; McCarty DM
    Mol Ther; 2017 Mar; 25(3):792-802. PubMed ID: 28143737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mucopolysaccharidosis IIIB: oxidative damage and cytotoxic cell involvement in the neuronal pathogenesis.
    Villani GR; Di Domenico C; Musella A; Cecere F; Di Napoli D; Di Natale P
    Brain Res; 2009 Jul; 1279():99-108. PubMed ID: 19409882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Murine Model of Mucopolysaccharidosis IIIB Develops Cardiopathies over Time Leading to Heart Failure.
    Schiattarella GG; Cerulo G; De Pasquale V; Cocchiaro P; Paciello O; Avallone L; Belfiore MP; Iacobellis F; Di Napoli D; Magliulo F; Perrino C; Trimarco B; Esposito G; Di Natale P; Pavone LM
    PLoS One; 2015; 10(7):e0131662. PubMed ID: 26147524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum MIP-1 alpha level: a biomarker for the follow-up of lentiviral therapy in mucopolysaccharidosis IIIB mice.
    Di Natale P; Di Domenico C; Di Napoli D
    J Inherit Metab Dis; 2010 Apr; 33(2):159-65. PubMed ID: 20162365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal MRI brain volume changes over one year in children with mucopolysaccharidosis types IIIA and IIIB.
    Abreu NJ; Selvaraj B; Truxal KV; Moore-Clingenpeel M; Zumberge NA; McNally KA; McBride KL; Ho ML; Flanigan KM
    Mol Genet Metab; 2021 Jun; 133(2):193-200. PubMed ID: 33962822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of heparin cofactor II-thrombin complex as a biomarker on blood spots from mucopolysaccharidosis I, IIIA and IIIB mice.
    Langford-Smith K; Arasaradnam M; Wraith JE; Wynn R; Bigger BW
    Mol Genet Metab; 2010 Mar; 99(3):269-74. PubMed ID: 19926322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastrointestinal pathology in a mouse model of mucopolysaccharidosis type IIIA.
    Roberts AL; Howarth GS; Liaw WC; Moretta S; Kritas S; Lymn KA; Yazbeck R; Tran C; Fletcher JM; Butler RN; Byers S
    J Cell Physiol; 2009 May; 219(2):259-64. PubMed ID: 19170061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell-Mediated Immunity to NAGLU Transgene Following Intracerebral Gene Therapy in Children With Mucopolysaccharidosis Type IIIB Syndrome.
    Gougeon ML; Poirier-Beaudouin B; Ausseil J; Zérah M; Artaud C; Heard JM; Deiva K; Tardieu M
    Front Immunol; 2021; 12():655478. PubMed ID: 34040605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum global metabolomics profiling reveals profound metabolic impairments in patients with MPS IIIA and MPS IIIB.
    Fu H; Meadows AS; Pineda RJ; Mohney RP; Stirdivant S; McCarty DM
    Metab Brain Dis; 2017 Oct; 32(5):1403-1415. PubMed ID: 28382573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-dose, continuous enzyme replacement therapy ameliorates brain pathology in the neurodegenerative lysosomal disorder mucopolysaccharidosis type IIIA.
    King B; Hassiotis S; Rozaklis T; Beard H; Trim PJ; Snel MF; Hopwood JJ; Hemsley KM
    J Neurochem; 2016 May; 137(3):409-22. PubMed ID: 26762778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Murine mucopolysaccharidosis type VII: the impact of therapies on the clinical course and pathology in a murine model of lysosomal storage disease.
    Vogler C; Sands MS; Galvin N; Levy B; Thorpe C; Barker J; Sly WS
    J Inherit Metab Dis; 1998 Aug; 21(5):575-86. PubMed ID: 9728337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.